Followers | 0 |
Posts | 885 |
Boards Moderated | 0 |
Alias Born | 02/15/2016 |
Monday, February 26, 2018 5:28:01 PM
I usually look at the cash flow statement to see how much cash they are burning through as a more important measurement.
They burned through 3mill last year 2017 and 2.3mill in 2016 which isnt terrible for a pharma play.
They have 8 million in the bank.
Not terribly concerned here.
That number the net cash used in operating activities obviously needs to turn around and fast but they should have revenue starting to come in this year.
thoughts?
these certifications like the they got in europe aint cheap.
the barriers to entry for a legit pharma company in this space are high.
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM